Stay updated with breaking news from Maxcyte Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MaxCyte, Inc. (NASDAQ:MXCT – Get Free Report) CEO Maher Masoud acquired 70,443 shares of the stock in a transaction dated Monday, June 10th. The stock was bought at an average cost of $4.90 per share, with a total value of $345,170.70. Following the completion of the purchase, the chief executive officer now owns 100,000 shares […]
Cadian Capital Management LP bought a new position in shares of MaxCyte, Inc. (NASDAQ:MXCT – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 5,644,898 shares of the company’s stock, valued at approximately $26,531,000. MaxCyte comprises 1.1% of Cadian Capital […]
Cadian Capital Management LP acquired a new position in MaxCyte, Inc. (NASDAQ:MXCT – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 5,644,898 shares of the company’s stock, valued at approximately $26,531,000. MaxCyte comprises about 1.1% of Cadian […]
MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference Rockville, MD, May 29, 2024- MaxCyte, Inc., , a leading, cell-engineering focused...
Investegate announcements from Participation in Upcoming Investor Conference